Project Grant HT94252510896
- The University of Texas Health Science Center at Houston received a $950,743 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding will support the "FUNCTIONAL OUTCOMES AND BIOMARKERS IN OCCUPATIONAL BLAST EXPOSURE (FOB: OBE): THE IMPACT ON SERVICE MEMBERS, VETERANS, AND THEIR FAMILIES" research project over a performance period from September 15, 2025 to September 14, 2029. The project...
- The U.S. Department of Defense's Defense Health Agency has awarded a $4,613,247 Project Grant titled "SHINING LIGHT ON TRAUMA: TREATMENT OF CHRONIC TBI TO IMPROVE PSYCHOLOGICAL HEALTH USING PHOTOBIOMODULATION IN SERVICE MEMBERS, VETERANS AND FIRST RESPONDERS" to the Western Institute For Veterans Research (WIVR), a non-profit organization in Salt Lake City, Utah. The grant, funded through the Military Medical Research and Development program (CFDA 12.420), will support research into...
- This $1,949,901 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding research by the Salisbury Foundation For Research And Education, doing business as Hefner Ba Medical Center, to investigate the relationship between blast exposure and cellular senescence in veterans. The 4-year research project, which began on September 1, 2025, aims to advance scientific understanding of the long-term health impacts of military...
- The Project Grant award titled "POINT-BLAST: POINT-OF-CARE BLOOD-BASED BIOMARKERS FOR DETECTING AND MONITORING EFFECTS OF REPETITIVE SUBCONCUSSIVE BLAST EXPOSURE IN MILITARY SERVICE MEMBERS" was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. This $1,985,067 award to the Medical College of Wisconsin, Inc. is focused on developing innovative point-of-care blood-based biomarkers to detect and monitor the...
- The Bronx Veterans Medical Research Foundation, Inc. (BVMRF) received a $1,961,254 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant is for a "Multimodal Molecular Study of Active Pathophysiological Pathways of Blast Injury and Neurotrauma in Military Tactical Training Operations" and will run from September 15, 2025 to September 14, 2029. BVMRF, a non-profit organization specializing in...
- The Defense Health Agency awarded a $1.5 million Project Grant to the Western Institute For Veterans Research to support the POSITIONED (PRECISION, STANDARDIZATION AND ORGANIZATIONAL READINESS IN TBI CARE) program. This funding will support the Military Medical Research and Development program's goal of transforming health care for Service Members and the public through innovative medical research solutions for the battlefield. Specifically, the POSITIONED program will conduct research from...
- The Project Grant award of $3,208,546.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports the expansion of the Generalized Blast Exposure Value Tool to determine cumulative blast exposure thresholds in military populations. The award was granted to the Rector & Visitors of the University of Virginia, a prominent public research university, on May 15, 2025, with a completion date of May 14, 2029. The goal of this research...
- This federal Project Grant award of $1,314,065.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research on the dose-response relationship of acute traumatic brain injury (TBI) blood biomarkers with pathoanatomic neuroimaging findings. The project will be conducted by the University of California, San Francisco (UCSF) over a period of 3 years from September 1, 2025 to August 31, 2028. The research...
- The U.S. Defense Health Agency awarded a $616,150 Project Grant to The Johns Hopkins University to support the "BLAST-EXPOSURE OUTCOMES AND ASSOCIATED LONG-TERM SYMPTOM TRAJECTORIES RELATED TO ESSENTIAL RECOVERY-PATHWAYS (BOLSTER) BIOMARKER INITIATIVE" under the Military Medical Research and Development program (CFDA 12.420). The project aims to conduct advanced biomedical research to transform healthcare for military service members, veterans, and the broader public by developing...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is focused on identifying diagnostic biomarkers related to the cerebrovascular contributions to cognitive impairment in repeated blast concussion. The $1,999,996.00 grant was awarded to Temple University on June 1, 2025, with a planned completion date of May 31, 2029. The research is expected to transform healthcare for military service members, veterans, and the...
The federal Project Grant award titled "FUNCTIONAL OUTCOMES AND BIOMARKERS IN OCCUPATIONAL BLAST EXPOSURE (FOB: OBE): THE IMPACT ON SERVICE MEMBERS, VETERANS, AND THEIR FAMILIES" is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This $1,051,179 grant, awarded on September 15, 2025, supports research conducted by the Western Institute For Veterans Research (WIVR), a non-profit organization based in Salt Lake City, Utah. The project aims to advance medical research and develop healthcare solutions for military service members, veterans, and their families, with a focus on understanding and treating complex medical conditions resulting from blast exposure during military service. The research will investigate functional outcomes and biomarkers related to occupational blast exposure, with the goal of transforming military healthcare and improving treatment protocols for affected individuals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.1m | 8/15/25 |